School of Medicine


Showing 11-20 of 20 Results

  • Ruoxi Pi

    Ruoxi Pi

    Postdoctoral Scholar, Infectious Diseases

    BioI received my BS in Biological Sciences in Zhejiang University in China, where I conducted research in polyphasic taxonomy in anaerobic bacteria. I received my PhD in Yale University, where I studied the early events of retrovirus infection in animal models. Now in the Blish lab, I am investigating NK cell responses during HIV-1 infection and trying to manipulate the NK cells to target latently infected cells.

  • Malvika Pillai

    Malvika Pillai

    Postdoctoral Scholar, Biomedical Informatics

    BioMalvika Pillai is a postdoctoral scholar at Stanford University in Medicine (Biomedical Informatics) in the Boussard Lab. She received her BS in Quantitative Biology and PhD in Health Informatics from the University of North Carolina at Chapel Hill. Her current work focuses on the development, evaluation and implementation of machine learning algorithms for clinical decision support.

  • Roel Polak

    Roel Polak

    Postdoctoral Scholar, Hematology

    BioAs a doctor and researcher, I am driven by curiosity and intrigued by the unknown. In the clinics, my days are filled with ‘real-life biology’ and the joy of interacting with the most pure and honest people in the world: children. In the research lab, my curiosity is driven by the complexity of the disease cancer and it’s microenvironment. I am an unbiased thinker and can easily adapt plans and ideas based on obtained data. My pro-active attitude and eye for detail helped me master multiple complex techniques, start collaborations, and push projects to the next level. In my view, combining fundamental & translational research is the way forward to find a cure for every child with cancer. My postdoctoral fellowship at Stanford University will therefore focus on the establishment of novel comprehensive organoid models for pediatric cancers.

  • Kathleen Dantzler Press

    Kathleen Dantzler Press

    Postdoctoral Scholar, Infectious Diseases

    BioThroughout my scientific training, I have focused on building an interdisciplinary background in molecular parasitology, biochemistry, immunology, and public health to provide me with the skills needed to pursue development of a successful malaria vaccine. My PhD research at Harvard centered on understanding immune responses to the developing transmission stages of malaria. By providing the first evidence for natural immunity to immature transmission stages, this work supports interrupting development and maturation of these parasites as a novel approach to transmission-blocking vaccine design. During my postdoctoral fellowship and in the future, I hope to continue researching host-pathogen interactions with applications to malaria vaccine development, while also being involved in global health work in the field. Currently my work focuses on understanding mechanisms of natural immunity to malaria and immune tolerance, particularly in the context of gamma delta T cell and monocyte responses.

  • Krishna Pundi

    Krishna Pundi

    Postdoctoral Medical Fellow, Cardiovascular Medicine
    Fellow in Medicine

    BioKrishna Pundi, MD is a Fellow in Cardiovascular Medicine at Stanford University. He received his MD from Mayo Medical school and completed internal medicine residency at Stanford University. Following internal medicine residency, Dr. Pundi received a combined appointment as a clinical instructor in hospital medicine and a post-doctoral research fellow for the ENHANCE-AF clinical trial as part of the AHA’s Strategically Focused Research Networks. Dr. Pundi then started Cardiovascular Medicine Fellowship at Stanford University in July 2020.

    Dr. Pundi’s research interest is in combining traditional epidemiologic approaches of understanding disease with novel methods of data acquisition to define clinical, demographic, and arrhythmia morphology features that predict cardiovascular events and death. He was recently awarded an ACC/Bristol Myers Squibb Research Fellowship Award to study the practice variation and treatment outcomes for patients with non-sustained ventricular tachycardia.